Related Experiment Video
Updated: Jun 16, 2026
07:52
A Mouse 5/6th Nephrectomy Model That Induces Experimental Uremic Cardiomyopathy
Published on: November 7, 2017
Cardiorenal syndrome and heart failure
Jason Reinglas1, Haissam Haddad, Ross A Davies
1University of Ottawa Heart Institute, Ontario, Canada.
Current Opinion in Cardiology
|February 19, 2010
Summary
Anemia, heart failure, and kidney disease often coexist. This review explores the complex cardiorenal syndrome, its mechanisms, and management strategies for improved patient outcomes.
Area of Science:
- Cardiology
- Nephrology
- Internal Medicine
Background:
- Heart failure and renal disease frequently occur together in patients.
- Anemia is a central factor, acting as both a cause and consequence of heart and kidney dysfunction.
- Cardiorenal syndrome describes the intricate interplay between cardiac and renal systems.
Purpose of the Study:
- To review current definitions and pathophysiological mechanisms of cardiorenal syndrome.
- To discuss the management and treatment options for patients with coexisting heart failure, renal disease, and anemia.
Main Methods:
- This is a review article.
- It synthesizes current literature on cardiorenal syndrome.
- Focuses on definitions, mechanisms, and clinical management.
Main Results:
- Cardiac dysfunction can precipitate kidney dysfunction, and vice versa.
- Heart failure is a common cardiovascular complication in renal failure.
- Anemia plays a critical role in the cardiorenal relationship.
Conclusions:
- Cardiorenal syndrome is a complex condition requiring multidisciplinary collaboration.
- Early recognition of cardiorenal syndrome is crucial for effective treatment and survival.
- Understanding this syndrome impacts patient management and prognosis.
Related Concept Videos
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
01:29Heart Failure II: Pathophysiology
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
01:27Heart Failure I: Introduction
Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
01:17Pathophysiology of Heart Failure
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
01:22Heart Failure Drugs: Diuretics
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
01:30Heart Failure V: Medical Management
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...